Arthur D Newell

Title: Arthur D Newell: Innovator in Vaccine Adjuvants

Introduction

Arthur D Newell is a notable inventor based in Orinda, CA (US). He has made significant contributions to the field of immunology, particularly in the development of vaccine adjuvants. With a total of 6 patents to his name, Newell's work has had a profound impact on enhancing immune responses in both animals and humans.

Latest Patents

One of Newell's latest patents focuses on the use of human interleukin-2 (IL-2) as a vaccine adjuvant. This innovative method enhances the immune response to vaccination by administering IL-2 as part of the vaccination regimen, preferably for 5 to 14 days post-vaccination. The compositions developed for this purpose employ IL-2 as an active ingredient, specifically human IL-2, to improve the efficacy of vaccines.

Career Highlights

Throughout his career, Arthur D Newell has worked with prominent companies in the biotechnology sector, including Chiron Corporation and Cetus Corporation. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of Newell's notable coworkers include Michael V Doyle and Jack H Nunberg. Their collaborative efforts have further advanced the research and development of vaccine technologies.

Conclusion

Arthur D Newell's innovative work in vaccine adjuvants exemplifies the importance of research in enhancing immune responses. His contributions continue to influence the field of immunology and pave the way for future advancements in vaccination strategies.